Document is current

Any future updates will be listed below

The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma

Crossref DOI link: https://doi.org/10.1186/s12885-015-1363-1

Published Online: 2015-05-08

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark